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The epidermal portion of the skin consists of the epidermis and its
appendages. These epithelia can give rise to a wide spectrum of tumors,
naturally or experimentally; however, owing to the topographic
proximity of the several normal skin epithelia (e.g., epidermis, sweat
duct, hair follicle), the cellular origin of many of these non-melanoma
skin cancers are unknown. In this report we examine the role of the hair
follicle or ‘‘pilosebaceous unit,’’ as opposed to the interfollicular
epidermis, in the development of non-melanoma skin cancer.
The majority of experimental skin carcinogenesis work has been
performed in animals, especially mice. Early work used complete
carcinogenesis protocols on strains of inbred Swiss mice; however, more
recent studies have utilized two-stage carcinogenesis protocols and
SENCAR mice that were bred for their extreme sensitivity to the initiator
7,12-dimethylbenz(a)antracene (DMBA) and the promoter 12-0-tetra-
decanoylphorphol-13-acetate (TPA) [1,2]. Rabbits and rats have also
been used. Because different results are frequently obtained from these
different animals, it is important to bear in mind potential species
differences.
Three broad theoretical constructs underlie modern thinking about
skin carcinogenesis. The first is our current understanding of how
organized populations of cells, such as the epidermis, reproduce
themselves (reviewed in [3,4]), with ‘‘stem cells,’’ ‘‘transient-amplifying
cells,’’ and ‘‘terminally differentiated cells’’ representing different stages
in the mixed process of reproduction and differentiation. The second is
our current concept of two-stage carcinogenesis (reviewed in [5–7]),
which involves separate steps of initiation, promotion, and conversion. A
third assumption in modern carcinogenesis thinking relates to the role of
hair follicles in skin cancer formation. Work with two-stage chemical
carcinogenesis protocols [8,9] has suggested that the act of initiation is
irreversible. Initiated animals can be promoted months to years after the
initial insult, and the yield of tumor production does not diminish
significantly. This has led to the generally accepted notion that tumor
initiation must involve primarily a population of long-lived cells (i.e., the
stem cells). We emphasize, however, that this assumption, reasonable as
it may seem, has not yet been rigorously proved, because we are unable
to distinguish, morphologically or by any other means, the stem cells
from cells that have already existed from the stem-cell compartment. In
this regard, the question of the role of interfollicular epidermis versus
follicular epithelium in skin cancer production becomes really a question
of where the skin’s stem cells are located and which ones are most
sensitive to carcinogenic effects.
Much of the evidence suggesting a role for hair follicles in skin cancer
formation comes from experiments performed in the 1950s and 1960s.
Recent re-assessment of epidermal stem-cell location has raised new
interest in this issue. Four lines of research suggest the importance of the
hair follicle in skin carcinogenesis. Each is examined individually.
HAIRED AND HAIRLESS SKIN
Some of the earliest work suggesting a role for hair follicles in skin cancer
development compares tumor development in haired versus hairless
mouse skin. In a pioneering study in 1946, Lacassagne and Latarjet [10]
created scars on the backs of newborn and adult mice with ultraviolet
radiation or excision. In those scars that healed without hair follicles,
tumors did not appear after treatment with 3-3 methylcholanthrene (MCA).
Only the periphery of scars, where hair follicles were present, developed
ulcerated tumors, which underwent histologically verified malignant
transformation. Histologically, the border region from which the
papillomas appeared to arise most frequently showed a persistent, marked
epithelial and follicular hyperplasia. The authors concluded that hair
follicles appear to play an important role in the genesis of skin tumors.
Similar studies over the subsequent 25 years examined tumor
development in strains of haired and hairless mice and in newborn
mice before and after hair development. Contradictory results were
obtained, probably because rudimentary follicular structures were
actually present in many of the hairless mice (reviewed in [11]). To
circumvent earlier errors of experimental design, Giovanella et al [11]
compared tumorigenesis in strains of hairless versus haired (Swiss) mice
using a two-stage protocol of DMBA initiation to the backs of mice,
followed by croton oil promotion at weekly or biweekly intervals. In
newborn mice, when skin of the hairless strain still contains follicles, all
treated animals developed papillomas and carcinomas: 70 haired mice
developed 66 papillomas and 11 carcinomas, and 34 hairless mice
developed 34 papillomas and three carcinomas. However, in adults a
clear differential was noted in that 13 haired mice developed 87
papillomas and three carcinomas, whereas 44 ‘‘hairless’’ mice developed
only seven papillomas and no carcinomas. Thus, Giovanella et al [11]
suggested that hairless mice were refractory to chemical carcinogenesis.
Iversen and Iversen [12] disputed this concept, as they demonstrated by
using Oslo hr/hr hairless mouse that carcinomas could be induced by
using a complete carcinogenesis protocol of a single application of MCA.
Several factors should be considered in trying to evaluate these disparate
findings: 1) different strains of hairless mice were used that might have
different sensitivities to the chemical carcinogens; 2) a two-stage protocol
was compared with a one-stage protocol; 3) Giovanella et al [11] used
acetone as a vehicle, whereas Iversen and Iversen used benzene [12],
which is itself a mild carcinogen; and, finally, 4) animals of different ages
were used by these two groups.
SKIN GRAFTING
A second line of evidence implicating hair follicles in skin carcinogenesis
comes from skin-grafting work with mice performed in the 1950s and
1970s. Billingham et al [13] in 1951 performed an interesting series of
experiments transplanting skin grafts of several thicknesses from
carcinogen-treated sites on mice to untreated sites on the same mice,
and vice versa. Epidermal grafts contained 1) epidermis only; 2) thin
‘‘Thiersch grafts’’ that included epidermis and papillary dermis but rarely
sebaceous glands; 3) thick Thiersch grafts that included sebaceous glands
but no hair bulbs; or 4) pinch grafts that included epidermis and dermis as
well as underlying adipose and muscle layers. Carcinogen treatments
consisted of 0.3% MCA applied once weekly for 12 weeks, followed by a
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2-week rest before grafting. When normal epidermis was grafted onto
carcinogen-treated dermis (the recipient site being treated with carcino-
gen followed by removal of its epidermis by the taking of a thin Thiersch
graft), 13 of 21 animals developed eight papillomas and six carcinomas at
the grafted sites. When the reverse was performed (i.e., when
carcinogen-treated epidermis was grafted onto untreated dermal beds),
none of the 28 animals developed tumors at the site of grafting; however,
at the carcinogen-treated donor sites, 14 of the 28 animals developed six
papillomas and 16 carcinomas. These first two experiments by Bill-
ingham et al [13] strongly implicate the lower half of the follicle (below
the level of a thin Thiersch graft) as a primary source of epidermal-
derived cancers.
Two additional sets of experiments attempted to further localize the
sites of cancer origin. Carcinogen-treated, thick Thiersch grafts were
transplanted onto untreated fascial beds devoid of epidermis, dermis, or
fat. Small but equal numbers of animals developed tumors at both
recipient and donor sites. At the grafted recipient sites, five of 30 animals
developed three papillomas and two carcinomas, whereas at the donor
sites, five developed one papilloma and five carcinomas. When an
identical experiment was performed using pinch grafts, similar results
were obtained. At the graft sites, three of 23 animals developed tumors,
and at the donor sites, three of 23 developed tumors. It is difficult to
interpret the latter pinch-grafting experiment because pinch grafts are
usually thinner peripherally and thicker centrally and thus contain
varying amounts of skin elements present at different depths. However,
the thick Thiersch-graft work suggests that the level at which these
Thiersch grafts are taken –between the sebaceous gland and the hair bulb
– is a primary site for tumor origin because division at this level leads to
equal numbers of tumors in the donor and recipient sites. The lower
absolute numbers of tumors produced may simply reflect cellular
damage, by incision at this level, to stem cells located there. This
localization of tumor origin is especially interesting in light of recent
work by Cotsarelis et al [4] in which follicular stem cells were found
by the tritiated thymidine-label – retaining technique to be located
in the bulge of the follicle, a structure located between the sebaceous
gland and the hair bulb [14]. This subject is discussed in more detail in a
following section.
An elegant recreation of the first experiment of Billingham et al [13]
was performed by Steinmuller [15] in 1971. In this instance, untreated
epidermis from one strain of mice was grafted onto previously
carcinogen-treated dermis of another strain of mice. As before, 53 of
63 animals developed carcinomas at the recipient site of grafting.
Histocompatibility studies of 14 of these tumors revealed that all of them
had arisen from the recipient as opposed to the donor mouse strain.
These results again strongly implicate follicular structures as a primary
source of epidermal tumor origin. In toto, skin-grafting studies support a
primary role for the hair follicle as a source from which the chemically
induced skin tumors arise.
HISTOLOGIC STUDIES
A third way in which investigators have attempted to determine the site of
origin of skin cancers has been to microscopically look for that site of
origin in very early tumors in animals and in humans. Zackheim
performed careful histologic analyses of chemically induced skin cancers
in rats, and noted that basal cell carcinomas (BCCs) arose from follicular
appendages [16], whereas squamous cell carcinomas (SCCs) arose
primarily from interfollicular epidermis [17]. In studies in humans,
Zackheim observed early BCCs developing from both follicular structures
and interfollicular epidermis [18]. Pinkus [19] noted that actinic
keratoses, a precursor lesion of SCCs, form initially in interfollicular
regions and then enlarge to include follicular epidermis as well. These
microscopic studies thus suggest that SCCs arise primarily from
interfollicular regions, whereas BCCs develop in follicular sites, although
in humans, BCCs may arise from interfollicular sites as well [20]. It is
interesting to note here the difference that host species and specific
carcinogenic exposure make in analyzing ‘‘skin cancer production.’’
How these differences relate to the role of pilosebaceous structures in
skin cancer development is still unclear. In humans, the great majority of
‘‘spontaneous’’ skin cancers that occur are BCCs [20]. In these instances,
the common carcinogenic exposure is probably to ultraviolet light from
the sun; however, following chemical carcinogen exposure, tumors that
subsequently develop are almost exclusively of the SCC variety [5].
In mouse skin, chemical carcinogenesis produces almost exclusively
squamous papillomas and carcinomas [21]. In rats, the most common
spontaneous skin tumor is the SCC [22]. Tumor development in rats
following chemical exposure depends on the specific carcinogen used
and, in fact, its route of application. Zackheim [22] noted that topical
application of 2-aminoanthracene to rats produced primarily BCCs: 87%
of animals developed BCCs, whereas only 36% developed SCCs. Topical
application of MCA produced similar results: 90% developed BCCs, but
only 26% developed SCCs. Topical application of DMBA, however,
resulted in a majority of SCCs: 73% of animals developed SCCs, whereas
only 32% developed BCCs [22]. Zackheim also observed the histologic
changes that followed topical application of each carcinogen [24]. He
noted that only DMBA produced a scarring alopecia. He suggested that
this follicular loss might be a reason for SCCs predominating following
DMBA application, as the source of origin for BCC development was
gone [16]. Of note, Bennington et al [23] found that with intravenous
DMBA application, six of 70 rats developed only tumors with
pilosebaceous differentiation. Here, no scarring alopecia resulted.
Finally, in rabbits [25], investigators have noted a preponderance of
keratoacanthoma-like lesions following carcinogen application. Further
advances in our knowledge of stem-cell types and location will hopefully
explain some of these interspecies and specific carcinogen-related
differences in cancer production.
HAIR CYCLE
Clinical Results A fourth way that the possible role of hair follicles in skin
cancer development has been studied is the application of carcinogens to
animals during discrete phases of their hair cycle. In many animals,
unlike humans, hair cycles are largely synchronous. Growth (anagen
phase) occurs in waves [26–29] that spread rapidly in a head-to-tail
fashion; a similar transition into the involu-tional (catagen) and resting
(telogen) phases is noted. The hair ‘‘cycle’’ is repeated several times
during the life of an individual animal. This synchrony makes hair cycle-
dependent carcinogenesis experiments possible; however, because
variations exist in the cycles of individual animals based on species,
gender, litter, and age, accurate determination of phase at the time
of carcinogen application is essential for appropriate interpretation
of the data.
It has been known for many years that application of carcinogen to
animals during different phases of their hair cycle (anagen versus telogen)
leads to differences in tumor development [30]. Mice and, to a lesser
extent, rabbits have been most extensively studied. Andreasen and
Engelbreth-Holm [31] found a striking increase in papilloma formation
when complete carcinogen was applied to the backs of mice during
telogen as opposed to anagen phase. A single 0.05-ml dose of 0.5%
DMBA in benzene was applied to 164 Swiss mice after determining each
mouse’s hair-cycle phase by skin biopsy (this often can result in a wound-
healing reaction that can greatly complicate the interpretation of these
results). The animals were followed for 10 weeks. Of those in telogen at
the time of carcinogen application, 37 of 68 developed papillomas; of
those in anagen, only six of 56 did. In addition, ‘‘pre-cancerous lesions,’’
appearing to represent regions of epilation and ulceration that were never
biop-sied, developed in 87% of the telogen animals but in only 16% of
the anagen ones. Borum [32] used a similar protocol with 100 Swiss mice
and obtained similar results. Hair dyeing was used instead of skin biopsy
to determine hair-cycle phase, and all animals were followed for 13
weeks. Forty of 45 animals in telogen phase at the time of carcinogen
application developed papillomas; none of 55 animals in anagen phase
did. Prolonged epilation and ulceration with subsequent scar formation
following carcinogen application in telogen but not anagen phase was
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again noted. Within the telogen tumors, 10 were noted to regress, and
two developed into SCCs.
A third and very interesting series of experiments with mice was
performed by Berenblum et al [33]. In two experiments, DMBA was
applied as a complete carcinogen to the backs of Swiss mice, and results
were similar to previous work. Seventeen of 24 animals with carcinogen
applied during telogen developed papillomas after 10 weeks, whereas
none of 34 anagen-applied animals did. Prolonged ulceration leading to
scarring was again noted clinically only in the telogen group. In the
second experiment, DMBA was applied at the onset of telogen in one
group of animals and near the end of telogen in another. Differential
tumor production resulted; nine of 11 early telogen applications but only
two of 32 late telogen applications resulted in papilloma formation. This
again suggested an important role for telogen as opposed to anagen
phase in tumor formation.
These investigators performed a second set of experiments that
utilized for the first time a cycle-specific, two-stage carcinogenesis
protocol. Of interest, in these experiments, no difference in tumor
development was seen after telogen versus anagen initiation. Hair phases
were again verified by a hair-dyeing technique. In the first experiment,
animals were initiated by a single application of 0.5% DMBA in benzene
(a treatment that can in itself produce cycle-specific differences in
papilloma formation) and were promoted 10 weeks later. After 10 weeks
of promotion, using biweekly application of 0.5% croton oil in liquid
paraffin, papilloma formation was 100% in both groups. In a second,
similar study, 0.3% DMBA in liquid paraffin (a topical solution that is in
itself unable to produce tumors after solitary application in previous
experiments) was applied during a specific hair phase as an initiator and
followed 2 weeks later with 20 biweekly croton oil applications for
promotion. Again, 100% papilloma formation occurred in both telogen
and anagen animal groups.
Superficially, Berenblum’s series of experiments [33] suggest that
although complete (one-step) carcinogen protocols are hair-cycle
dependent, as previous studies have indicated, two-stage carcinogenesis
protocols are not. However, the difference in the results of the two
protocols might be interpreted in several ways. First and most simply, it is
possible that the differences between the anagen and telogen initiation
were obscured (considering that both animals yielded 100% papilloma
formation). Second, owing to an overdose of carcinogens, none of the
above-noted investigators, including Berenblum et al [33], followed their
complete carcinogen-protocol animals for 20 weeks. Thus, one cannot
rule out the possibility that tumor development in animals with anagen-
applied carcinogen might occur more slowly. In other words, this
equalization of tumor formation between anagen and telogen groups of
animals might have occurred later, even in the one-stage protocol, but
was missed because of insufficient observation time.
Experiments by Whiteley suggest that hair-cycle phase in rabbits
influences not only the number of tumors that develop but their type as
well. In one study [34], Shope papilloma virus was inoculated onto 14
chinchilla rabbits that had half of their quiescent back hairs artificially
stimulated to enter anagen phase by hair plucking. Contrary to the mouse
results, numerous rapidly growing tumors developed in anagen skin
areas, but only a few slowly growing ones occurred in telogen regions. In
a second experiment [35], 2% DMBA in lanolin was applied weekly for
5 months to the backs of 18 rabbits in different stages of the hair cycle.
After 7 months of observation, 598 papillomas had developed, again
almost all within regions of anagen skin, and 11 became SCCs. During
the same time period, 296 keratoacanthoma-like ‘‘self-healing tumors’’
developed, primarily in regions of telogen follicles, and approximately 10
of these also became invasive. These data suggest that during different
phases of the hair cycle, either the cell type being stimulated or the
character of the stimulation itself is different.
A final caveat with regard to the influence of hair cycles on skin
tumorigenesis is that growth cycles have been noted to morphologically
alter not only follicular cells but also interfollicular skin cells [27,36]. In
fact, the overall thickness of skin increases during anagen phase due
primarily to a marked increase in the thickness of the subcutis, with a
slight thinning of the epidermis and dermis; the skin thickness decreases
during telogen. This means that stem-cell changes may occur in both
follicular and interfollicular regions. Therefore, conclusions focusing
exclusively on the role of follicles during changes in the hair cycle must
be viewed with caution.
Histologic Changes Histologic changes of mouse skin after carcinogen
application differ when application is made during different phases of the
hair cycle. Studies of the effects of MCA application [36,37] reveal
degeneration of both interfollicular epidermis and follicles in the central
region of carcinogen application, with an accompanying hyperplasia of
these structures peripherally. In the central region, persistent lower
portions of damaged follicles develop into proliferating, cyst-like
structures. Peripherally, hyper-plastic interfollicular epidermis and
atypical follicular patterns involving enlargement and fusion of neighbor-
ing follicles with loss of sebaceous glands are seen. With time and
especially after repeated carcinogen applications, irregularities in the
maturation of the surrounding hyperplastic areas are noted. Papillomas
and carcinomas develop within these hyperplastic regions [38].
Studies of hair-cycle-specific carcinogen application reveal signifi-
cant differences in the ensuing histologic changes. Liang and Cowdry
[36] observed that follicular alterations following an MCA application on
mouse back skin are much more frequent with hairs in telogen as
opposed to anagen phase. Montagna and Chase [39] found that
sebaceous gland regrowth after a single MCA application occurs much
more slowly when the follicles are in telogen as opposed to anagen
phase. Andreasen and Borum [40] noted distinct histologic differences in
mouse skin following DMBA application in telogen as opposed to anagen
phase. With telogen application, a central degeneration with peripheral
hyperplasia, like that described for non-cycle-specific carcinogen
application above, was noted. Following anagen application, however,
interfollicular epidermis and follicular outer root sheaths thickened, and
sebaceous glands disappeared, but no other structural change to the
follicles was noted. Argyris [41] showed that following MCA application,
telogen-phase skin accumulates glycogen, but anagen-phase skin does
not. In toto, these histologic studies indicate that carcinogen application
is clinically and histologically much more destructive when applied
during the telogen rather than the anagen phase. A possible explanation
for this is that carcinogens are accumulated for a longer period of time in
telogen follicles owing to a lack of inner root sheath, which normally
seals the hair canals (see below).
Carcinogen Localization Several experimental techniques have been
used to localize carcinogen within the skin immediately following
topical or systemic application. Most reveal a diffuse presence that
involves both follicular and interfollicular skin. Only a few studies have
compared application during different hair-cycle phases.
Fluorescence studies of hair follicles [42] show MCA immediately
after application to be most prominent in the sebaceous glands and in the
lipid layers of keratinized epithelium, including the follicles. Over the
next several days, excretion of carcinogen-containing sebum onto the
surface of the skin occurs, and this is ultimately exfoliated. Berenblum
et al [33] noted a clear difference in the persistence of DMBA when it
was applied during the anagen versus telogen phases of the hair cycle.
Application during the anagen phase disappeared over 1–4 d, whereas
application during telogen persisted for 10 d. Berenblum et al [33]
theorized that inactivity of sebaceous glands during telogen, with a
resulting lack of a sebum flow, allows DMBA persistence during this
phase and contributes to the increased tumor production with telogen
application of carcinogen that they observed.
Autoradiographic localization of tritiated DMBA [43] and 3,4-
benzopyrene (BP) [44] 1–72h after application reveals a diffuse presence
in the epidermis and sebaceous glands and in the follicle, above the level
of the sebaceous duct. Electron microscopic examination of BP [44] and
MCA [45] reveals carcinogen to be diffusely present in the nucleus and
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cytoplasm along nuclear and cytoplasmic membranes and at the
dermoepidermal junction. Dermal mast cells in skin to which DMBA has
been applied are also labeled [46]. In an early study, Borum [47] compared
the application of I4C labeled DMBA during anagen and telogen phases of
hair growth. A diffuse presence was noted in both instances. A very
interesting, more recent, autoradiographic study was performed by Morris
et al [48]. They observed labeled BP in mouse skin up to 1 month after
application. Initially, a diffuse epidermal and sebaceous gland presence
was noted; however, 1 month after application, only 2% of interfollicular
epidermal cells and 4% and 5% of infundibular and external root sheath
cells, respectively, were still labeled. Seventy percent of the interfollicular
epidermal cells were located at the center of the so-called epidermal
proliferative units, where epidermal stem cells are said to reside [3,49].
Additional application of TPA to the skin resulted in an increased mitotic
rate in these labeled cells, with no displacement from the basal layer. This,
too, reflects a stem-cell -like activity. When a double-labeling experiment
was performed to compare BP retention with the thymidine retention
(indicative of stem cells), double-labeling of nuclei in some cells in both
interfollicular and follicular locations was noted. This study suggests that
carcinogen is retained by slow-recycling stem cells, although a specific
comparison of follicular and interfollicular sites was not made [49].
Furthermore, distribution of the BP at different phases of the hair cycle was
not investigated.
Finally, detection of carcinogen-DNA adducts in mouse skin by
32P- post-labeling analysis [50] reveals that 1) covalent binding of
carcinogen to DNA occurs, and 2) although the majority of the adducts
disappear in the 2 weeks following carcinogen application, a fraction
persists for as long as 5 months. This longevity again suggests a presence
in long-lived, non-differentiating cells (i.e., stem cells). Comparison of
adducts by location or after phase-specific carcinogen application has
not yet been done.
HAIR-FOLLICLE STEM CELLS
Experimental work thus suggests an important role for the hair follicle in
skin cancer development. As mentioned previously, it is generally
accepted that a subpopulation of cells having stem-cell characteristics
are the target cells that interact with carcinogens and eventually become
transformed [48,51–53]. Because the hair follicle is a self-renewing
tissue, by definition it must contain stem cells (for a review of stem cells
in general, see [54,55]). Thus, knowledge of the location and biologic
properties of hair-follicle stem cells is crucial to our understanding of skin
cancer/hair follicle interrelationships.
On the basis of our experience in studying epidermal [56,57] and
corneal epithelial stem cells [58,59], we learned that one of the most
diagnostic criteria for identifying keratinocyte stem cells is their slow
cycling nature [54]. Because stem cells are slow cycling [55], a single
pulse of [3H]thymidine (TdR) will not be incorporated by these cells.
Continuous exposure of TdR is necessary to ensure incorporation by stem
cells, which rarely divide; however, tissue hyperproliferation can
enhance the incorporation of TdR by stem cells [59]. Once labeled,
cells that cycle slowly will retain the TdR for a long period of time and
thus can be identified as label-retaining cells (LRCs) [49,60]. When we
Figure 1. Localization of slow-cycling cells detected as LRCs in the mouse hair follicle, (a) Survey photomicrograph of murine hair follicles 4 weeks after a
long-term (14 day) exposure to TdR, showing the relationship of the bulge region (*) to the matrix keratinocytes (M) of the bulb; (E) epidermis; (S) sebaceous
gland, (b) Portion of the bulge region (shown in a) with cells having prominently labeled, irregularly shaped nuclei (arrows), (c) Portion of the bulb area (shown in
a) with numerous mitotic figures (arrows) present in matrix (M) keratinocytes. Note absence of any labeled nuclei in this region.
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located LRCs in the mouse pelage hair follicle, we were unable to find
any slow-cycling cells in the matrix keratinocytes of the bulb
(Figure la, c), which was thought to be the site of follicular stem cells
[61,63]. Instead, we found a population of LRCs in the outer root sheath
of the upper follicle in an area called the bulge (Fig 1a, b) [4].
Cells of the bulge area possess the following features: 1) this area is
the insertion site of the arrector pili muscle [14], and it marks the lower
end of the permanent portion of the hair follicle; 2) these cells have an
ultrastructurally primitive cytoplasm [4]; 3) although they are normally
slow cycling, they undergo a transient phase of cell proliferation during
early anagen and can be stimulated to proliferate by hair plucking,
retinoic acid, and TPA [64]; and 4) they are located in a physically well-
protected and highly vascularized area. We recently obtained similar
results from two specialized hairs – vibrissae and eyelash follicles [64]. A
population of slow-cycling cells was localized in the outer root sheath of
the vibrissa follicle at the level of the ringwulst and ring sinus; an area
analogous to the bulge in pelage hairs. Similarly, in eyelash a population
of LRCs was exclusively observed in the outer root sheath in a region
corresponding to the bulge. Again, LRCs were not detected in the matrix
keratinocytes comprising the bulb region of vibrissae or eyelash follicles,
even though these specialized hairs have relatively long anagen phases.
On the basis of these findings, we have proposed that the bulge was the
site of the hair-follicle stem cells [4,64,65].
Additional support for this conclusion is derived from a critical
reevaluation of some previous experiments whose biologic significance
was unclear. For example, Oliver [66–68] demonstrated that the lower half
of rat vibrissae hair follicles could be removed, and a new hair bulb could
regenerate after implantation of a new follicular papilla. (Although this
group of cells is customarily known as dermal papilla cells, it may be more
precise to call them ‘‘follicular papilla’’ to distinguish them from the ‘‘dermal
papilla,’’ which are the pegs of connective tissue that interdigitate with the
epidermal rete ridges forming the dermal/epidermal junction (A. Bernard
Ackerman, personal communication).) This indicates that the upper portion
of the hair follicle is ‘‘indispensible.’’ Similarly, surgical removal of the lower
half of human axillary hair follicles did not impede the formation of new
follicles [69]. Taken together, these previous observations support our new
model that the upper portion of the follicle, not the bulb region, is the site of
the follicular stem cells.
The identification of putative stem cells in the upper portion of the
hair follicle led us to develop a ‘‘bulge-activation hypothesis,’’ which
provided for the first time a unifying concept that explains many
paradoxical properties of the hair follicle. This model (Fig 2) takes into
account many important events known to occur during various phases of
the hair cycle [4,65]. The first tenent of this model is that during late
telogen or early anagen, the normally slow-cycling stem cells of the
bulge area are transiently activated, presumably by signals from the
abutting follicular papilla, and proliferate. We recently showed that
during the onset of early anagen in both the second and third hair cycles
in SENCAR mice, cells in the bulge region indeed became ‘‘activated’’
and proliferated, as evidenced by the presence of TdR and the detection
of mitotic figures in these cells. With the formation of the new epithelial
downgrowth, only matrix keratinocytes were pulse labeled with TdR,
whereas bulge cells returned to a quiescent state at this time [64]. We
believe that the downward migration of follicular papilla cells away from
the bulge area results in the return of the bulge cells to their normal
quiescent state [4,65].
A second aspect of the hypothesis concerns the activation of the
normally quiescent follicular papilla by the matrix keratinocytes during
mid-anagen. Although the follicular papilla appears to be dormant during
most phases of the hair cycle, Pierrard and de la Brassinne [70] showed
that during mid-anagen, follicular papilla cells undergo transient
proliferation, resulting in the formation of new blood vessels and the
‘‘loosening up’’ of the mesenchymal cells. Because matrix keratinocyte
proliferation clearly precedes that of the follicular papilla, we hypothe-
sized that matrix keratinocytes stimulate follicular papilla cells to
undergo transient proliferation.
Third, matrix keratinocytes are capable of TdR incorporation after a
single-pulse exposure, which indicates that these cells have a relatively
rapid cycle time; a feature consistent with transient amplifying cells
[4,52], Because such transient amplifying cells, by definition, have only a
limited proliferative potential, they eventually exhaust their replicative
ability and undergo terminal differentiation. This results in the bulb
undergoing a degenerative or apoptotic phase (catagen).
The fourth feature concerns the follicular papilla-epithelial interaction
during catagen, when the papilla condenses and is connected to the
degenerating matrix by a ‘‘connective tissue sheath.’’ The connective tissue
sheath contracts during catagen, and the follicular papilla is pulled upward
and eventually comes to rest in the vicinity of the bulge. A default in this
upward movement can result in a failure of subsequent hair cycles,
presumably due to the inability of the bulge cells to become activated [71].
CONCLUSIONS AND PERSPECTIVES
The data that we have summarized here clearly indicate that there is a
close relationship among the hair cycle, skin carcinogenesis, and
follicular stem cells. Many issues centering around the cellular origin
and clinical relevance of experimentally induced skin tumors need to be
resolved. Although it seems clear that the hair cycle (anagen versus
telogen) can influence the outcome of tumor initiation and subsequent
tumor yield, how this occurs is unclear. Furthermore, do tumors arising
from one-stage carcinogenesis protocols behave (progress) differently
than tumors developing from a two-stage protocol when the stage of the
hair cycle is considered? Most important, what is the cellular origin of the
tumors produced by these different protocols? Is it possible that some
tumors are follicle-derived, whereas others are derived from the
interfollicular epidermis? A systematic and critical reexamination of the
role of the hair follicle in skin-tumor formation, using experimental
approaches, is needed to answer these fundamental questions of
cutaneous carcinogenesis.
Figure 2. Bulge-activation hypothesis: (APM) arrector pili muscle, (B) bulge,
(C) cortex, (DP) dermal papilla, (E) epidermis, (IRS) inner root sheath, (M)
matrix, (Md) medulla, (ORS) outer root sheath, and (S) sebaceous gland. (B)
and (B*) denote quiescent and activated bulge cells, respectively. (From [4];
reproduced with permission.)
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